Born from a relentless pursuit to reverse Ankylosing Spondylitis, Helixis is a clinical-grade data synthesis engine.
Helixis processes raw blood panels (uploaded as PDFs or images), extracting and structuring biomarkers (ApoB, hs-CRP, HbA1c) and benchmarking them against optimal functional ranges for performance and inflammation control.
Integrate high-impact Single Nucleotide Polymorphisms (SNPs) including MTHFR C677T/A1298C, HLA-B27, COMT, and APOE to map specific metabolic and methylation pathways.
Our AI engine synthesizes peer-reviewed studies and clinical methodologies popularized by leading longevity pioneers: Medicine 3.0 baselines (Dr. Peter Attia), gut barrier protection (Dr. Steven Gundry), methylation pathways (Gary Brecka), and biological aging rates (Bryan Johnson).
Helixis is a clinical-grade health optimization operating system born directly from our founder’s 13-year journey of successfully reversing Ankylosing Spondylitis—a chronic, progressive autoimmune spine condition associated with the HLA-B27 genetic marker. It is far more than a biomarker database; it is a synthesis engine that combines patient empathy and deep functional medicine knowledge with advanced AI reasoning to construct a concrete, actionable plan for you to take back control of your health.
Helixis Health is built for two primary cohorts: autoimmune patients managing chronic conditions who seek root-cause resolution, and biohackers, longevity optimizers, or Medicine 3.0 adherents looking to optimize biomarkers, genetics, and biometrics via an advanced AI Digital Twin.
Helixis vision extraction benchmarks raw biomarkers against optimal functional ranges rather than standard clinical reference ranges designed to detect manifest disease.
Helixis specializes in mapping high-impact genetic SNPs including MTHFR, HLA-B27, COMT, and APOE.